Jasper Therapeutics, Inc. (JSPR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 20.29M | 34.65M | 54.56M | 42.97M | 53.17M | 75.81M | 94.81M | 108.68M | 120.31M | 88.94M | 105.22M | 118.57M |
| Cash & Short-Term Investments | 14.14M | 28.69M | 50.9M | 39.51M | 48.8M | 71.64M | 92.5M | 106.82M | 118.47M | 86.89M | 103.87M | 115.81M |
| Cash Only | 14.14M | 28.69M | 50.9M | 39.51M | 48.8M | 71.64M | 92.5M | 106.82M | 118.47M | 86.89M | 103.87M | 115.81M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 250K | 250K | 250K | 250K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.15M | 5.95M | 3.67M | 1.94M | 854K | 646K | 625K | 475K | 440K | 309K | 749K | 1.5M |
| Total Non-Current Assets | 892K | 1.13M | 2.9M | 3.5M | 4.42M | 4.09M | 4.61M | 5.25M | 5.66M | 5.95M | 5.19M | 5.6M |
| Property, Plant & Equipment | 398K | 604K | 2.34M | 2.89M | 3.47M | 2.85M | 3.18M | 3.67M | 3.81M | 4.19M | 4.36M | 4.74M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 417K | 0 | 417K | 417K | 417K | 417K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 494K | 530K | 150K | 609K | 532K | 820K | 1.01M | 1.16M | 1.84M | 1.76M | 828K | 862K |
| Total Assets | 21.18M | 35.78M | 57.47M | 46.47M | 57.6M | 79.9M | 99.41M | 113.93M | 125.96M | 94.89M | 110.41M | 124.17M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -63.22% | -55.22% | -42.19% | -59.21% | -54.27% | -15.8% | -9.96% | -8.25% | -9.22% | 96.22% | 86.78% | 76.46% |
| Total Current Liabilities | 9M | 13.2M | 21.04M | 20.5M | 12.33M | 15.24M | 12.46M | 10.07M | 8.92M | 12.37M | 11.91M | 8.97M |
| Accounts Payable | 2.44M | 6.22M | 9.17M | 8.03M | 3M | 4.03M | 3.09M | 2.96M | 2.39M | 4.15M | 3.26M | 1.58M |
| Days Payables Outstanding | 18.55K | - | - | - | - | - | - | - | 1.03K | - | - | - |
| Short-Term Debt | 757K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.8M | 5.75M | 10.17M | 105K | 1.83M | 3.7M | 8.31M | 467K | 1.27M | 2.08M | 420K | 389K |
| Current Ratio | 2.26x | 2.62x | 2.59x | 2.10x | 4.31x | 4.98x | 7.61x | 10.79x | 13.49x | 7.19x | 8.84x | 13.22x |
| Quick Ratio | 2.26x | 2.62x | 2.59x | 2.10x | 4.31x | 4.98x | 7.61x | 10.79x | 13.49x | 7.19x | 8.84x | 13.22x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 8.79M | 18.43M | 24.86M | 2.46M | 3.02M | 2.99M | 3.27M | 3.55M | 3.82M | 4.08M | 4.37M | 4.99M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 201K | 755K | 724K | 1.01M | 1.29M | 1.55M | 1.81M | 2.07M | 2.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.79M | 18.43M | 24.86M | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.3M | 2.68M |
| Total Liabilities | 17.78M | 31.63M | 45.9M | 22.96M | 15.35M | 18.23M | 15.73M | 13.62M | 12.73M | 16.45M | 16.27M | 13.96M |
| Total Debt | 757K | 1.24M | 1.7M | 2.15M | 2.59M | 1.81M | 2.07M | 2.32M | 2.55M | 2.79M | 3.01M | 3.23M |
| Net Debt | -13.39M | -27.46M | -49.2M | -37.35M | -46.21M | -69.82M | -90.43M | -104.5M | -115.92M | -84.1M | -100.85M | -112.58M |
| Debt / Equity | 0.22x | 0.30x | 0.15x | 0.09x | 0.06x | 0.03x | 0.02x | 0.02x | 0.02x | 0.04x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 3.4M | 4.15M | 11.57M | 23.5M | 42.24M | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M | 94.13M | 110.2M |
| Equity Growth % | -91.95% | -93.27% | -86.17% | -76.57% | -62.69% | -21.37% | -11.1% | -8.98% | -9.56% | 117.96% | 97.9% | 87.48% |
| Book Value per Share | 0.22 | 0.27 | 0.70 | 1.53 | 2.81 | 4.11 | 5.58 | 6.69 | 8.49 | 7.10 | 8.58 | 10.09 |
| Total Shareholders' Equity | 3.4M | 4.15M | 11.57M | 23.5M | 42.24M | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M | 94.13M | 110.2M |
| Common Stock | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 11K | 11K |
| Retained Earnings | -317.84M | -316.67M | -307.57M | -288.83M | -262.11M | -240.87M | -216.55M | -197.91M | -183.33M | -169.6M | -153.02M | -135.47M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |